Form 8-K Keros Therapeutics, Inc. For: Jul 17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Keros Therapeutics CFO resigns, interim finance chief named
July 22, 2026 4:05 PM EDTKeros Therapeutics (NASDAQ: KROS) announced that Keith Regnante resigned as Chief Financial Officer, effective August 3, 2026, to pursue other opportunities. The company stated his departure was voluntary and not the result of any disagreement over accounting practices, financial statements, internal controls, or company policies.
The company's Board of Directors appointed Annita... More
